0001127602-24-007883.txt : 20240301 0001127602-24-007883.hdr.sgml : 20240301 20240301162642 ACCESSION NUMBER: 0001127602-24-007883 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240228 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAUNDERS BRENT L CENTRAL INDEX KEY: 0001268854 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41380 FILM NUMBER: 24710295 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD STREET 2: C/O SCHERING PLOUGH CORP CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch & Lomb Corp CENTRAL INDEX KEY: 0001860742 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 520 APPLEWOOD CRESCENT CITY: VAUGHAN STATE: A6 ZIP: L4K 4B4 BUSINESS PHONE: 908-541-5456 MAIL ADDRESS: STREET 1: 520 APPLEWOOD CRESCENT CITY: VAUGHAN STATE: A6 ZIP: L4K 4B4 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-02-28 0001860742 Bausch & Lomb Corp BLCO 0001268854 SAUNDERS BRENT L C/O BAUSCH + LOMB CORPORATION 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 ONTARIO, CANADA 1 1 CEO and Chair 0 Common Shares, No Par Value 2024-02-28 4 A 0 187919 0 A 562919 D Non-Qualified Stock Options (right to purchase) 16.85 2024-02-28 4 A 0 569105 0 A Common Shares, No Par Value 569105 569105 D Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Reflects the grant of stock options to purchase common shares under the Plan. The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. The stock options will expire on the tenth anniversary of the grant date. /s/ Debra E. Levin, attorney-in-fact 2024-03-01